Open Access
Open access
volume 6 issue 41 pages 27089-27100

1,2,3-Triazoles of 8-Hydroxyquinoline and HBT: Synthesis and Studies (DNA Binding, Antimicrobial, Molecular Docking, ADME, and DFT)

Publication typeJournal Article
Publication date2021-10-06
scimago Q1
wos Q2
SJR0.773
CiteScore7.1
Impact factor4.3
ISSN24701343
General Chemistry
General Chemical Engineering
Abstract
A new series of 1,2,3-triazole hybrids containing either 2- or 4-hydroxyphenyl benzothiazole (2- or 4-HBT) and naphthalen-1-ol or 8-hydroxyquinoline (8-HQ) was synthesized in high yields and fully characterized. In vitro DNA binding studies with herring fish sperm DNA (hs-DNA) showed that quinoline- and 2-HBT-linked 1,2,3-triazoles of shorter alkyl linkers such as 6a are better with a high binding affinity (3.90 × 105 L mol-1) with hs-DNA as compared to naphthol- and 4-HBT-linked 1,2,3-triazoles bound to longer alkyl linkers. Molecular docking of most active 1,2,3-triazoles 6a-f showed high binding energy of 6a (-8.7 kcal mol-1). Also, compound 6a displayed considerable antibacterial activity and superior antifungal activity with reference to ciprofloxacin and fluconazole, respectively. The docking results of the fungal enzyme lanosterol 14-α-demethylase showed high binding energy for 6a (-9.7 kcal mol-1) involving dominating H-bonds, electrostatic interaction, and hydrophobic interaction. The absorption, distribution, metabolism, and excretion (ADME) parameter, Molinspiration bioactivity score, and the PreADMET properties revealed that most of the synthesized 1,2,3-triazole molecules possess desirable physicochemical properties for drug-likeness and may be considered as orally active potential drugs. The electrophilicity index and chemical hardness properties were also studied by density functional theory (DFT) using the B3LYP/6-311G(d,p) level/basis set.
Found 
Found 

Top-30

Journals

2
4
6
8
10
12
14
Journal of Molecular Structure
14 publications, 15.73%
ACS Omega
9 publications, 10.11%
ChemistrySelect
7 publications, 7.87%
Synthetic Communications
4 publications, 4.49%
Future Medicinal Chemistry
3 publications, 3.37%
Pharmaceuticals
2 publications, 2.25%
Research on Chemical Intermediates
2 publications, 2.25%
Journal of Biomolecular Structure and Dynamics
2 publications, 2.25%
New Journal of Chemistry
2 publications, 2.25%
Heliyon
2 publications, 2.25%
Bioorganic Chemistry
2 publications, 2.25%
Russian Journal of General Chemistry
2 publications, 2.25%
Current Topics in Medicinal Chemistry
1 publication, 1.12%
Pharmaceutics
1 publication, 1.12%
Materials Today: Proceedings
1 publication, 1.12%
Journal of the Indian Chemical Society
1 publication, 1.12%
European Journal of Medicinal Chemistry
1 publication, 1.12%
Expert Opinion on Drug Discovery
1 publication, 1.12%
Medicinal Chemistry Research
1 publication, 1.12%
Sensors & Diagnostics
1 publication, 1.12%
Inorganic Chemistry Communication
1 publication, 1.12%
Archiv der Pharmazie
1 publication, 1.12%
Analytical Methods
1 publication, 1.12%
Chemical Papers
1 publication, 1.12%
Green Chemistry
1 publication, 1.12%
Green Chemistry Letters and Reviews
1 publication, 1.12%
Russian Journal of Organic Chemistry
1 publication, 1.12%
Scientific Reports
1 publication, 1.12%
Indian Journal of Microbiology
1 publication, 1.12%
2
4
6
8
10
12
14

Publishers

5
10
15
20
25
30
Elsevier
26 publications, 29.21%
Taylor & Francis
12 publications, 13.48%
Springer Nature
12 publications, 13.48%
Wiley
10 publications, 11.24%
American Chemical Society (ACS)
9 publications, 10.11%
Royal Society of Chemistry (RSC)
6 publications, 6.74%
MDPI
5 publications, 5.62%
Pleiades Publishing
3 publications, 3.37%
Bentham Science Publishers Ltd.
1 publication, 1.12%
Scientific Publishers
1 publication, 1.12%
Research Square Platform LLC
1 publication, 1.12%
IGI Global
1 publication, 1.12%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 1.12%
Asian Journal of Chemistry
1 publication, 1.12%
5
10
15
20
25
30
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
89
Share
Cite this
GOST |
Cite this
GOST Copy
Nehra N., Tittal R. K., Ghule V. D. 1,2,3-Triazoles of 8-Hydroxyquinoline and HBT: Synthesis and Studies (DNA Binding, Antimicrobial, Molecular Docking, ADME, and DFT) // ACS Omega. 2021. Vol. 6. No. 41. pp. 27089-27100.
GOST all authors (up to 50) Copy
Nehra N., Tittal R. K., Ghule V. D. 1,2,3-Triazoles of 8-Hydroxyquinoline and HBT: Synthesis and Studies (DNA Binding, Antimicrobial, Molecular Docking, ADME, and DFT) // ACS Omega. 2021. Vol. 6. No. 41. pp. 27089-27100.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1021/acsomega.1c03668
UR - https://doi.org/10.1021/acsomega.1c03668
TI - 1,2,3-Triazoles of 8-Hydroxyquinoline and HBT: Synthesis and Studies (DNA Binding, Antimicrobial, Molecular Docking, ADME, and DFT)
T2 - ACS Omega
AU - Nehra, Nidhi
AU - Tittal, Ram K.
AU - Ghule, Vikas D.
PY - 2021
DA - 2021/10/06
PB - American Chemical Society (ACS)
SP - 27089-27100
IS - 41
VL - 6
PMID - 34693129
SN - 2470-1343
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2021_Nehra,
author = {Nidhi Nehra and Ram K. Tittal and Vikas D. Ghule},
title = {1,2,3-Triazoles of 8-Hydroxyquinoline and HBT: Synthesis and Studies (DNA Binding, Antimicrobial, Molecular Docking, ADME, and DFT)},
journal = {ACS Omega},
year = {2021},
volume = {6},
publisher = {American Chemical Society (ACS)},
month = {oct},
url = {https://doi.org/10.1021/acsomega.1c03668},
number = {41},
pages = {27089--27100},
doi = {10.1021/acsomega.1c03668}
}
MLA
Cite this
MLA Copy
Nehra, Nidhi, et al. “1,2,3-Triazoles of 8-Hydroxyquinoline and HBT: Synthesis and Studies (DNA Binding, Antimicrobial, Molecular Docking, ADME, and DFT).” ACS Omega, vol. 6, no. 41, Oct. 2021, pp. 27089-27100. https://doi.org/10.1021/acsomega.1c03668.